Abstract
Background: Maximal safe resection followed by concomitant chemoradiotherapy (CCRT) and adjuvant temozolomide is the standard-of-care first-line treatment for patients with glioblastoma. However, whether there exists an optimal interval between surgery and CCRT remains debated. Our study aims to examine whether an earlier initiation of CCRT after resection improves overall survival (OS).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical oncology (Royal College of Radiologists (Great Britain))
Paper Title
Journal
Date
